Deutsche Märkte geschlossen

Univec, Inc. (UNVC)

OTC Markets OTCPK - OTC Markets OTCPK Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
0,0054+0,0004 (+8,00%)
Börsenschluss: 03:59PM EDT

Univec, Inc.

822 Guilford Avenue
Suite 208
Baltimore, MD 21202
United States

BrancheMedical Care Facilities

Leitende Angestellte

Dr. David DaltonCEO, President & Director39,93kN/A1949
Mr. Michael A. LesiskoChief Financial Officer, Secretary and Treasurer12,5kN/A1949
Mr. Raphael LangfordChief Operating Officer and Executive Vice President13,33kN/A1944
Die Beträge haben den Stand 31. Dezember 2003 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.


Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.

Corporate Governance

Univec, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.